NIHR launches second £20 million Long COVID funding call
25 March 2021
The NIHR has launched a second call for research proposals on helping and supporting people with Long COVID.
25 March 2021
The NIHR has launched a second call for research proposals on helping and supporting people with Long COVID.
25 March 2021
A new NIHR funded study is being launched to reduce the number of people who die in the months following a stay in hospital with COVID-19.
03 March 2021
A NIHR-supported study evaluating potential COVID-19 treatments that can be taken at home will now expand for the first time to include adults of any age
22 February 2021
Vaccination has been linked to a substantial reduction in the risk of Covid-19 admissions to Scotland’s hospitals, landmark research suggests.
18 February 2021
The NIHR and UK Research and Innovation (UKRI) have funded four new research studies to better understand and address the longer term effects of COVID-19 on physical and mental health.
12 February 2021
NIHR and UK Research and Innovation have jointly funded eight new research projects in a second round of rapid-response research to tackle COVID-19 in low- and middle-income countries.
11 February 2021
The NIHR-supported RECOVERY trial has shown that tocilizumab - an anti-inflammatory rheumatoid arthritis treatment - reduces the risk of death for hospitalised patients with severe COVID-19.
11 February 2021
NIHR-supported researchers have created a new data tool to enable local authorities and the NHS to deliver targeted responses into communities at higher risk to COVID-19.
08 February 2021
The NIHR has launched a new call to fund research to compare head-to-head the clinical effectiveness of the licensed COVID-19 vaccines being used in the UK.
05 February 2021
Respiratory support used to treat patients with severe COVID-19 are associated with less aerosol emission than breathing, speaking or coughing, suggests new research funded by NIHR and UKRI.
04 February 2021
The study will examine using different approved vaccines for the two doses, as well as different intervals between doses, and is backed by £7 million of government funding.
02 February 2021
The NIHR-supported RECOVERY trial has begun investigating the anti-inflammatory arthritis drug, baricitinib, as a potential treatment for hospitalised COVID-19 patients.
02 February 2021
Patients across the UK who are admitted to intensive care units due to COVID-19 are set to receive a treatment that can reduce the time spent in hospital by up to 10 days, an international study supported by the National Institute for Health Research has found
29 January 2021
The NIHR-supported Novavax COVID-19 vaccine, developed by the US-based biotechnology firm, is 89.3% effective at preventing COVID-19, shown from interim analysis of its Phase III study data.
26 January 2021
A new trial funded by NIHR will look at reducing the transmission of Covid-19 and its severity in care homes.
25 January 2021
The NIHR-supported PRINCIPLE trial has found that the commonly used antibiotics, azithromycin and doxycycline, do not reduce recovery time for patients.
18 January 2021
Two flagship, NIHR-supported studies - REMAP-CAP and RECOVERY - have found no evidence of benefit from convalescent plasma as a treatment for hospitalised patients with COVID-19.
11 January 2021
The number of people seeking help for mental illness or self-harm during April 2020, while the UK was in full lockdown, dropped by more than a third, according to NIHR-funded research.
09 January 2021
Researchers have developed a new risk stratification tool that can accurately predict the likelihood of deterioration in adults hospitalised with COVID-19.
07 January 2021
Patients across the UK who are admitted to intensive care units due to COVID-19 are set to receive a treatment that can reduce the time spent in hospital by up to 10 days, an international study supported by the National Institute for Health Research has found.
30 December 2020
The Medicines & Healthcare Products Regulatory Agency (MHRA) has approved use of the COVID-19 vaccine developed by the University of Oxford and AstraZeneca for people in the UK.
25 December 2020
The world’s first participant in a new antibody treatment study to protect against COVID-19 has been recruited at the University College London Hospitals (UCLH) NHS Foundation Trust.
22 December 2020
Three clinical trial platforms working together to test the effects of full doses of anticoagulants (blood thinners) in COVID-19 patients have paused enrollment for one group of patients.
19 December 2020
The NIHR has published data on participation in COVID-19 urgent public health research by ethnicity - highlighting the importance of people of all ethnicities being represented in studies.
16 December 2020
A UK developed vaccine, pioneered by biotech company Valneva and the only one so far to use an inactive version of the virus, is to be trialled in the UK.